Cargando…
Adjuvant therapies for HIV-associated neurocognitive disorders
OBJECTIVE: HIV-associated neurocognitive disorder (HAND) is a frequent and heterogeneous complication of HIV, affecting nearly 50% of infected individuals in the combined antiretroviral therapy (cART) era. This is a particularly devastating statistic because the diagnosis of HAND confers an increase...
Autores principales: | McGuire, Jennifer L, Barrett, Jeffrey S, Vezina, Heather E, Spitsin, Sergei, Douglas, Steven D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265066/ https://www.ncbi.nlm.nih.gov/pubmed/25540809 http://dx.doi.org/10.1002/acn3.131 |
Ejemplares similares
-
Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders
por: McGuire, Jennifer L, et al.
Publicado: (2015) -
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV
por: Barrett, Jeffrey S., et al.
Publicado: (2016) -
HIV-associated neurocognitive disorders
por: Sanmarti, Montserrat, et al.
Publicado: (2014) -
HIV Associated Neurocognitive Disorders
por: Zhou, Li, et al.
Publicado: (2013) -
Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders
por: Woods, Steven Paul, et al.
Publicado: (2009)